Belinda A. Campbell
Peter MacCallum Cancer Centre
CancerInternal medicineRadiologySurgeryPathologyOncologyRetrospective cohort studyStage (cooking)Positron emission tomographyLung cancerChemotherapyFollicular lymphomaMycosis fungoidesLymphomaRituximabLimited StageNuclear medicineCancer researchRadiation therapyMedicine
Publications 65
#1Belinda A. Campbell (Peter MacCallum Cancer Centre)H-Index: 16
#2A. Lasocki (Peter MacCallum Cancer Centre)
Last. Greg Wheeler (Peter MacCallum Cancer Centre)H-Index: 14
view all 12 authors...
Abstract Aims Radiation-induced cavernomas (RIC) are common late toxicities in long-term survivors of malignancy following cerebral irradiation. However, the natural history of RIC is poorly described. We report the first series of long-term surveillance of RIC using modern magnetic resonance imaging (MRI) including highly sensitive susceptibility-weighted imaging (SWI). The aims of this research were to better characterise the natural history of RIC and investigate the utility of MRI-SWI for sc...
#1Belinda A. Campbell (Peter MacCallum Cancer Centre)H-Index: 16
#2Jason CallahanH-Index: 26
Last. Michael S. HofmanH-Index: 44
view all 5 authors...
ABSTRACT As a marker of cellular proliferation, 18F-fluorothymidine (FLT) PET can detect the distribution of proliferating hematopoiesis and has an emerging role in the investigation of hematopoietic disorders. These images demonstrate the novel utility of 18F-FLT PET for imaging sites of extramedullary hematopoiesis (EMH) in a patient with Chuvash-type polycythemia and suggest a role for 18F-FLT PET in response assessment following radiotherapy. Further, the discordant response observed in the ...
#1S.J. Newman (Peter MacCallum Cancer Centre)
#2N. Bucknell (Peter MacCallum Cancer Centre)
Last. Shankar Siva (Peter MacCallum Cancer Centre)H-Index: 30
view all 17 authors...
AIMS At diagnosis, <1% of patients with non-small cell lung cancer (NSCLC) have synchronous solitary brain metastasis (SSBM). In prior cohorts without 18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) staging, definitive treatment to intracranial and intrathoracic disease showed a 5-year overall survival (OS) of 11-21%. We investigated the long-term survival outcomes for patients with SSBM NSCLC, diagnosed in the FDG-PET/CT era and treated definitively with loca...
#1Friyana K. Bhabha (Peter MacCallum Cancer Centre)H-Index: 1
#2Christopher McCormack (Peter MacCallum Cancer Centre)H-Index: 22
Last. H. Miles Prince (Peter MacCallum Cancer Centre)H-Index: 3
view all 17 authors...
Primary cutaneous lymphomas represent a heterogeneous group of T- and B-cell lymphomas with distinct clinical presentations, histopathologic features, treatment approaches and outcomes. The cutaneous T-cell lymphomas, which include mycosis fungoides and Sezary syndrome, account for the majority of the cutaneous lymphomas. This Clinical Practice Statement is reflective of the current clinical practice in Australia. An expanded form of the Clinical Practice Statement (and updates), along with help...
#1Belinda A. Campbell (Peter MacCallum Cancer Centre)H-Index: 16
#2Amit Khot (Peter MacCallum Cancer Centre)H-Index: 12
The generally poor prognoses of patients with peripheral T-cell lymphoma (PTCL) highlight the inadequacies of current treatments. Traditionally, treatment paradigms were extrapolated from results o...
#1Crystal Gao (Monash University, Clayton campus)H-Index: 2
#2Christopher McCormack (St. Vincent's Health System)H-Index: 22
Last. H. Miles Prince (Monash University, Clayton campus)H-Index: 3
view all 11 authors...
4 CitationsSource
#1Rachel Brown (Royal Melbourne Hospital)
#2Alessandro Lambertini (Peter MacCallum Cancer Centre)
Last. Belinda A. Campbell (Peter MacCallum Cancer Centre)H-Index: 16
view all 9 authors...
#1Andrea Lo (UBC: University of British Columbia)H-Index: 10
#2Belinda A. Campbell (Peter MacCallum Cancer Centre)H-Index: 16
Last. Kerry J. Savage (UBC: University of British Columbia)H-Index: 71
view all 7 authors...
With a median follow-up of 16.6 years, Lo and colleagues report excellent long-term outcomes with primary radiotherapy for limited-stage follicular lymphoma in this month's CME article.
9 CitationsSource
#1Belinda A. Campbell (University of Melbourne)H-Index: 16
#2Julia ScarisbrickH-Index: 14
Last. H. Miles Prince (University of Melbourne)H-Index: 3
view all 6 authors...
Time to next treatment (TTNT) is an emerging endpoint in clinical studies of primary cutaneous T-cell lymphomas (CTCL), with utility as a surrogate marker for the "duration of clinical benefit". TTNT provides a highly clinically meaningful endpoint that uniquely reflects not only the duration of treatment efficacy on disease and symptom control, but also incorporates the patient experience by accounting for patient compliance and tolerance to the studied therapy(s). Given the distinct challenges...
5 CitationsSource